Hanyang University Guri Hospital
Gyeonggi-do 471-101
0 studies enrolling now · 7 studies all time
What they study most
Cardiovascular Risk, Chronic Kidney Disease, Crohn Disease, Crohn's Disease, Diabetes Mellitus, Type 2, Inflammation, Ulcerative Colitis
Studies at this site
- A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease — Recruiting now
- ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
- A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes — Completed
- Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease — Stopped early
- Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease — Completed
- A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission — Stopped early
- A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease — Completed